⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3070359 | 0.65 | NOTUM (0.33) | — | |
| SCHEMBL1727810 | 0.61 | — | — | |
| SCHEMBL28758681 | 0.61 | — | — | |
| SCHEMBL665313 | 0.61 | — | — | |
| SCHEMBL2842848 | 0.61 | — | — | |
| SCHEMBL23808321 | 0.60 | — | — | |
| SCHEMBL171550 | 0.60 | — | — | |
| SCHEMBL60018 | 0.60 | — | — | |
| SCHEMBL9697518 | 0.60 | — | — | |
| SCHEMBL2643021 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 589 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339904-A1 | ISOINDOLINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | 2023-10-26 | — | — | US | claimed |
| CN-107709658-B | Oxidation process | 卡特克塞尔科技有限公司 | 2021-04-09 | — | — | CN | claimed |
| EP-3307940-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | claimed |
| US-10815616-B2 | Oxidative method | CATEXEL TECHNOLOGIES LIMITED (GB) | 2020-10-27 | — | — | US | claimed |
| EP-2185549-B1 | ANTIMICROBIAL ORTHO-FLUOROPHENYL OXAZOLIDINONES FOR TREATMENT OF BACTERIAL INFECTIONS | MICURX PHARMACEUTICALS INC (KY) | 2018-10-03 | — | — | EP | claimed |
| US-20180094384-A1 | OXIDATIVE METHOD | CATEXEL B.V. (NL) | 2018-04-05 | — | — | US | claimed |
| CN-107709658-A | Method for oxidation | 卡特克塞尔科技有限公司 | 2018-02-16 | — | — | CN | claimed |
| EP-2220048-B1 | ARYL- AND HETEROARYLCARBONYL DERIVATIVES OF BENZOMORPHANES AND RELATED SCAFFOLDS, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND THEIR USE | BOEHRINGER INGELHEIM INT (DE) | 2017-01-25 | — | — | EP | claimed |
| US-9505750-B2 | 5-aminocyclylmethyl-oxazolidin-2-one derivatives | ACTELION PHARMACEUTICALS LTD. (CH) | 2016-11-29 | — | — | US | claimed |
| US-9469632-B2 | 6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists | ELI LILLY AND COMPANY (US) | 2016-10-18 | — | — | US | claimed |
| CN-1325388-A | Azacyclodepsipeptides and their use as parasiticides | BAYER AG (DE) | 2001-12-05 | — | — | CN | claimed |
| US-5866583-A | Substituted 2,4-diaminopyrimidines | HOFFMANN-LA ROCHE INC. (US) | 1999-02-02 | — | — | US | claimed |
| EP-0853626-A1 | SUBSTITUTED PHOSPHINIC COMPOUNDS AND THEIR USE AS PHARMACEUTICALS | Novartis AG (CH) | 1998-07-22 | — | — | EP | claimed |
| EP-0816379-A2 | DNA binding oligomers | BAYER AG (DE) | 1998-01-07 | — | — | EP | claimed |
| WO-1997009335-A1 | SUBSTITUTED PHOSPHINIC COMPOUNDS AND THEIR USE AS PHARMACEUTICALS | NOVARTIS AG (CH) | 1997-03-13 | — | — | WO | claimed |
| US-5446037-A | Antiallergens; elastase inhibitors | SYNPHAR LABORATORIES, INC. (CA) | 1995-08-29 | — | — | US | claimed |
| CN-1082547-A | Azabicyclic compounds | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-02-23 | — | — | CN | claimed |
| WO-1993021186-A1 | SUBSTITUTED 3-PYRROLIDINYLTHIO-CARBAPENEMS AS ANTIMICROBIAL AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-10-28 | — | — | WO | claimed |
| EP-0045049-B1 | ARYLAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MICROBICIDES | CIBA-GEIGY AG (CH) | 1985-06-26 | — | — | EP | claimed |
| EP-0045049-A2 | Arylamine derivatives, process for their preparation and their use as microbicides | CIBA-GEIGY AG (CH) | 1982-02-03 | — | — | EP | claimed |